Concurrent chemo-therapy for limited small cell carcinoma of lung
✍ Scribed by Lalitha M. Janaki; Walter Reed Army Medical Center
- Publisher
- Elsevier Science
- Year
- 1984
- Tongue
- English
- Weight
- 121 KB
- Volume
- 10
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twice‐daily radiotherapy (BIDRT) or once‐daily radiotherapy (QDRT) resulted in a better outcome for patients with limited‐st
## BACKGROUND. Although thoracic radiotherapy is considered to be useful for the treatment of patients with small cell lung carcinoma (SCLC), its optimal administration schedule is still controversial. ## METHODS. In a multicenter clinical trial, 164 patients with limited SCLC (of whom 156 were e
Multi-modality treatment consisting of cisplatin, VP-16, and 5-fluorouracil chemotherapy given concomitantly with external beam radiation was used to treat 64 patients with locally advanced Stage I11 non-small cell lung carcinoma. This regimen was used in a preoperative fashion for four cycles in pa